Trial Site Detail

 

Drug:	Regorafenib + Avelumab
Trial:	A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors (REGOMUNE)
Conditions:	Solid Tumors
Trial Status:	Recruiting

 

Institut Bergonie 229 Cours Argonne      Bordeaux , Gironde 33076 France

 

Principal Investigator:	Sophie Cousin, MD
Contact:	Contact: Sophie Cousin, MD Sub-Investigator: Antoine Italiano, MD, PhD
Activation Status of this Site:	Active
Notes about this Site:
Institut Bergonie Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.